Unity Biotechnology (STU:9U90) Pre-Tax Income : €-37.11 Mil (TTM As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Unity Biotechnology Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Unity Biotechnology's pretax income for the three months ended in Dec. 2023 was €-1.37 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was €-37.11 Mil. Unity Biotechnology's pretax margin was %.

During the past 8 years, Unity Biotechnology's highest Pretax Margin was -1269.34%. The lowest was -18842.80%. And the median was -3231.26%.

Unity Biotechnology Pre-Tax Income Historical Data

The historical data trend for Unity Biotechnology's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Unity Biotechnology Pre-Tax Income Chart

Unity Biotechnology Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Pre-Tax Income

Get a 7-Day Free Trial

-73.96

-77.14

-53.74

-41.98

-36.55

Unity Biotechnology Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Pre-Tax Income	Get a 7-Day Free Trial															1.22	-10.15	-11.27	-14.33	-1.37

Competitive Comparison of Unity Biotechnology's Pre-Tax Income

For the Biotechnology subindustry, Unity Biotechnology's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Unity Biotechnology's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Unity Biotechnology's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Unity Biotechnology's Pre-Tax Income falls into.

Unity Biotechnology Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Unity Biotechnology's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-35.823	+	-1.116	+	-2.248	+	2.635	+	0
	=	-36.55

Unity Biotechnology's Pretax Income for the quarter that ended in Dec. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-6.527	+	4.673	+	-0.001	+	0.481	+	4.4408920985006E-16
	=	-1.37

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-37.11 Mil.

Unity Biotechnology (STU:9U90) Pre-Tax Income Explanation

Unity Biotechnology's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	-1.374	/	0
	=	%

During the past 8 years, Unity Biotechnology's highest Pretax Margin was -1269.34%. The lowest was -18842.80%. And the median was -3231.26%.

Unity Biotechnology Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Unity Biotechnology's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Unity Biotechnology (STU:9U90) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Unity Biotechnology Inc (STU:9U90) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

UBX:USA 9U90:Germany

Address

285 East Grand Avenue, South San Francisco, CA, USA, 94080

Website

https://www.unitybiotechnology.com

Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases.

Unity Biotechnology (STU:9U90) Headlines

No Headlines